Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Байотек, Инк.filedCriticalЯнссен Байотек, Инк.
Priority claimed from PCT/US2020/031749external-prioritypatent/WO2020227457A1/en
Publication of EA202193035A1publicationCriticalpatent/EA202193035A1/en
Описаны антитела к TRGV9 или их антигенсвязывающие фрагменты. Также описаны нуклеиновые кислоты, кодирующие антитела, композиции, содержащие антитела, способы получения антител и способы применения антител для лечения или предотвращения заболеваний, таких как рак.Antibodies to TRGV9 or their antigen-binding fragments are described. Also described are nucleic acids encoding antibodies, compositions containing antibodies, methods for producing antibodies, and methods for using antibodies to treat or prevent diseases such as cancer.
EA202193035A2019-05-082020-05-07
MATERIALS AND METHODS FOR T-CELL-MEDIATED IMMUNE MODULATION
EA202193035A1
(en)